Latest Feature Articles

Unlocking the gateway to ‘precision’ UK market access

Business Services, Market Access, Market Access Consultancy, Sales and Marketing | NHS, Visions4Health

As the UK healthcare system navigates a period of significant change, the path to successful market access is becoming increasingly …

The unbearable lightness of creativity

Medical Communications, Sales and Marketing | 21GRAMS, Atomic Matter, Corporate, HAVAS LYNX, London UK, PM Society Awards, Pharmacy, pharma healthcare communications, pharma marketing

21GRAMS and Havas Lynx lead the charge at the PM Society Awards for pharma marketing and healthcare communications Commenting on …

EU regulatory momentum could catalyse clinical trial innovation

Regulatory Affairs, Research and Development | AI, Corporate, EU regulation, Hospital Management, Pharmacy, Veeva Systems

Dr Werner Engelbrecht at Veeva Systems discusses how compliance can be turned into a competitive advantage with connected platforms and …

Five Facts about mental health

Medical Communications, Medical Education, Research and Development | European Commission, Pharmacy, Psychiatry, mental health, mental health condition

32% of people suffer from at least one mental health issue, with daily struggles like financial and job insecurity being …

Rare disease clinical trials: the urgent need for patients to be heard

| Alexion, Pharmafocus, Rare Diseases, clinical trials, feature

Ahead of Clinical Trials Day, Soraya Bekkali, from Alexion, AstraZeneca Rare Disease, highlights the urgent need to elevate patients’ voices …

Sustainability in pharma

| Pharmacy, Pharmafocus, feature, sustainability

Betsy Goodfellow from Pharmafocus considers the need for sustainable practices in the pharma industry and assesses various sustainable advances that have already …

An overview of women’s health in 2024

| Reproductive health, abortion, fertility, reproductive health, women's health

Betsy Goodfellow from Pharmafocus considers the current landscape of women’s health, covering recent debates and ongoing issues within the reproductive health sphere …

Measles: the UK’s next epidemic?

| MMR, measles, vaccines

Recently, the UK has seen a rapid increase in the number of cases of measles, along with a drop in …

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Business Services |

PARIS, FRANCE, STRICTLY EMBARGOED until 11.00pm CET, 13 February 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced three-year minimum, …

Veeva la Vida: A Roundup of the R&D and Quality Summit 2022

|

Timeline On the 8 June, we had the pleasure of joining Veeva at their 2022 Life Sciences Summit in Zurich, …

Appy Days: How the smartphone app is revolutionising mental healthcare

|

Over the last decade, our individual awareness and understanding of mental health has risen to unprecedented levels. Despite its pitfalls, …

Injecting real-world data into every day clinical trials – RWE and RWD

|

The past two years have seen unprecedented pressure on healthcare systems, its workers, and clinical research as a whole. COVID-19 …

Preparation Preconditions: What measures are needed to combat another pandemic?

|

Could we have foreseen the damage caused by the COVID-19 pandemic? This is a central question that has plagued biopharma …

Shaping the new frontiers of women’s health

|

 March 8 was International Women’s Day and provided a perfect opportunity for Pharmafocus to dive deep into women’s health. Lina …

The Gateway to Local Adoption Series

Latest content